• Batimastat (BB-94): Potent MMP Inhibition in Cancer & Synapt

  2026-08-06

  Batimastat (BB-94) is a broad-spectrum matrix metalloproteinase (MMP) inhibitor with nanomolar potency, widely used in cancer and neuromuscular research. Its defined IC50 values and robust solubility in DMSO make it a benchmark tool for in vitro MMP inhibition assays and in vivo tumor growth studies. Supplied by APExBIO, Batimastat enables precise modulation of proteolytic activity in both preclinical oncology and neurobiology.

• Sulfo-NHS-SS-Biotin: Precision Cell Surface Protein Labeling

  2026-08-06

  The Sulfo-NHS-SS-Biotin Kit empowers researchers to selectively, efficiently, and reversibly label cell surface proteins—critical for advanced interactome mapping and purification workflows. Disulfide-cleavable linkage and true aqueous compatibility set this reagent apart for dynamic proteomics and glycoRNA studies.

• Cepharanthine Targets EGFR/PI3K/AKT in Nasopharyngeal Carcin

  2026-08-05

  This study demonstrates that cepharanthine (CEP), derived from Stephania cephalantha, inhibits nasopharyngeal carcinoma (NPC) progression by targeting the EGFR/PI3K/AKT/mTOR pathway. Integrating network pharmacology, molecular docking, and in vivo xenograft models, the research provides mechanistic evidence for CEP as a low-toxicity anti-NPC agent.

• KX2-391 dihydrochloride: Dual-Action Inhibitor in Bench Rese

  2026-08-05

  KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) uniquely targets both Src kinase and tubulin polymerization, enabling advanced experimental modeling across oncology, virology, and neurotoxin research. This article unpacks optimized workflows, troubleshooting strategies, and the cross-domain impact of dual mechanism inhibition for robust, reproducible results.

• Cholesterol Impedes Lipid Nanoparticle Trafficking and Deliv

  2026-08-04

  The referenced study uncovers how elevated cholesterol content in lipid nanoparticles (LNPs) disrupts their intracellular trafficking, leading to reduced nucleic acid delivery efficiency. By employing a streptavidin–biotin-DNA tracking platform combined with high-throughput imaging, the authors identify cholesterol-driven aggregation in early endosomes as a critical barrier to effective cargo release, informing future LNP formulation strategies.

• Annexin V-FITC/7-AAD Apoptosis Kit: Technical Workflow Guide

  2026-08-04

  The Annexin V-FITC/7-AAD Apoptosis Kit enables rapid, reliable discrimination of apoptotic and necrotic cells in cell viability and cytotoxicity assays using fluorescence microscopy or flow cytometry. It is not suitable for detailed mechanistic studies or unvalidated forms of cell death. For best results, follow recommended storage and protocol parameters, and routinely check workflow quality controls.

• Comparative Antibacterial Efficacy of Cefazedone and β-Lacta

  2026-08-03

  This article dissects a pivotal comparative study evaluating the antibacterial spectrum and potency of N-formimidoyl thienamycin (MK0787) against several recently developed β-lactam antibiotics, including cefazedone (Refosporen), across resistant clinical isolates. The findings provide crucial context for researchers optimizing in vitro antibacterial testing and inform protocol choices when targeting Gram-positive and Gram-negative pathogens.

• Optimizing hiPSC Platelet Differentiation via Small Molecule

  2026-08-03

  This study introduces a cost-effective, optimized protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs) by refining culture conditions and integrating small-molecule modulators. The approach significantly increases yield, reduces differentiation time, and lowers costs, providing a scalable platform for research and potential therapeutic applications.

• Ciprofloxacin Hydrochloride: From Antibacterial Mechanisms t

  2026-08-02

  Explore the multifaceted roles of ciprofloxacin hydrochloride, a fluoroquinolone antibiotic, from precise DNA replication inhibition to advanced immunomodulatory applications. This article delves deeper than existing content, offering new insights for translational and experimental research.

• DMXAA (Vadimezan): Mechanistic Insights and Assay Impact in

  2026-08-01

  Explore the multifaceted anti-cancer mechanisms of DMXAA (Vadimezan), including its effects on tumor vasculature, apoptosis, and kinase signaling. This article uniquely unpacks deep assay implications, bridging advanced cancer biology research with actionable protocol guidance.

• Naringenin Attenuates ER Stress–Driven Insulin Resistance in

  2026-07-31

  This study demonstrates that naringenin counteracts hepatitis C virus (HCV)-induced insulin resistance by suppressing endoplasmic reticulum (ER) stress and the IRE1α/XBP1 pathway in liver models. The findings clarify how ER stress links HCV infection to metabolic dysfunction and highlight molecular targets for future therapeutic research.

• Cabazitaxel (XRP6258): Technical Protocols for Resistant Mod

  2026-07-31

  Cabazitaxel (XRP6258) is a semi-synthetic taxane optimized for disrupting microtubule dynamics in taxane-resistant tumor models, especially those with P-glycoprotein-mediated chemoresistance. It is unsuitable for water-based assays and long-term solution storage, but provides reliable results in DMSO- or ethanol-based workflows when handled per technical guidelines.

• Talin1’s Role in Piezo1–YAP Axis and Endothelial Inflammatio

  2026-07-30

  This study uncovers how Talin1 modulates the Piezo1–YAP axis to drive endothelial inflammation and atherosclerosis. The findings provide mechanistic detail on calcium-dependent signaling in vascular disease and suggest new targets for anti-inflammatory intervention.

• Glucocorticoid Receptor Control of Hippocampal CYP in Phenyt

  2026-07-30

  This study uncovers a glucocorticoid receptor-dependent mechanism by which pregnenolone 16α-carbonitrile (PCN) suppresses hippocampal cytochrome P450 (CYP) expression, thereby attenuating phenytoin-induced neurotoxicity in mice. These findings clarify brain-specific regulation of CYP enzymes and suggest glucocorticoids as promising candidates for protecting neuronal health during antiepileptic therapy.

• Phosphatase Inhibitor Cocktail 2 (100X): Reliable Phosphoryl

  2026-07-29

  This article addresses real-world laboratory challenges in preserving protein phosphorylation during cell viability and signaling assays. Drawing on published evidence and validated best practices, we show how Phosphatase Inhibitor Cocktail 2 (100X in ddH2O), SKU K1013, ensures reproducible, high-sensitivity results across diverse workflows.

11452 records 1/764 page Next 12345 下5页 Last page